STE · STERIS plc

NYSE Health Care Large Cap Clavix A-
221.54−1.12  (−0.50%)

Price

Snapshot

50 fields · last close
Market Cap$21.71B
P/E26.97
Float97.14M
Beta0.88
Volatility21.9%
ExchangeNYSE
SectorHealth Care
Cap tierLarge cap
Macro sensitivityModerate
Clavix score81.3
Price221.54
Change−0.50%
Prev Close222.66
Open225.37
Day Low221.10
Day High226.72
Avg Vol1
Avg $ Vol$150.1M
52W High269.44
52W Low195.14
52W Pos35.5%
From High−17.78%
From Low+13.53%
Max DD 1Y−25.78%
Spread0.10%
LiquidityNormal
SMA 20+4.29%
SMA 50+0.09%
SMA 200−2.08%
RSI (14)62.0
Vol 30D20.0%
Vol 90D25.5%
1Y Range195–269
Daily bars536
Perf Week+3.85%
Perf Month+7.03%
Perf Quarter+3.82%
Perf Half Y−1.39%
Perf Year−5.96%
Perf YTD−11.40%
Prev Day−0.50%
ClavixA-
Debt / Eq0.25
Curr Ratio2.09
Int Cover23.0×
FCF Margin16.4%
Rev Growth+8.7%
ProfitProfitable
LeverageLow
Sector rank10 / 49

What STE does

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.

It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.

The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services.

It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting.

In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment.

It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals.

The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015.

STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Clavix risk grade

regraded every trading day
A-81.3/100

STE grades A-, 81.3 of 100. Steadiest on Macro Resilience (69), most exposed on News Sentiment (52, mixed). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 10 of 49 in Health Care by Clavix score.

PriceMacroSectorNewsFinancial

How rough the ride is

STEHealth Care median
Betavs the overall market · lower is steadier0.880.84
Volatilityannualized21.9%20.9%
Max drawdown, past yearworst peak-to-trough fall−25.8%—
Typical daily movemedian absolute daily change0.89%—
Days beyond ±3%of the last 252 sessions15 (6%)—

How its days are spread

Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.

52-week range

STE
222.66

The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.

Drawdown from the 1-year peak

STE

Percent below the running high over the last 12 months. Zero is a fresh high.

Market sensitivity

STEHealth Care median
Beta to the markethow much it swings with the S&P 500 · lower is safer0.880.84
Macro sensitivityrate, dollar and credit exposure bucketModerateModerate 53% of 49

Where it sits on the macro scale

Low 12Moderate 26High 8Very High 3

Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.

Where it ranks in its sector

Sector
Health Care49 companies ranked
STE
#10 of 49

Rank by Clavix score within the sector. Right is the top of the sector.

Price performance

STE
1 week+3.9%
1 month+7.0%
Year to date−11.4%
1 year−6.0%

Context for the rank, not itself a risk measure.

Recent coverage, scored

STE
Articles scoredthe most recent scored coverage, up to 3030 since 5 Aug
Average score0 most bearish, 100 most bullish63
Bullish · bearisharticles above 60 · below 4018 · 3
Directionarticles whose tone is improving vs worsening18 ↑ 3 ↓

Where the article scores land

Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.

Balance sheet, against the sector

Debt / equityTotal debt vs shareholder equity · lower is stronger
0.25sector median 0.65 · 49 names
Current ratioShort-term assets vs liabilities · higher is stronger
2.09sector median 1.69 · 49 names
FCF marginFree cash flow as a share of revenue · higher is stronger
16.4%sector median 10.6% · 49 names
Interest coverageOperating income vs interest expense · higher is stronger
23.0×sector median 6.3× · 44 names

The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.

Growth

STE
Revenue growthyear over year+8.7%

Financial Health is shown but does not count toward the grade. Why

0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.

Recent news

most recent scored articles · the chip is the article’s score · click to open

STERIS says its Healthcare segment is growing strongly, its Applied Sterilization Technologies (sterilization services) business prospects are improving, and demand from its Life Sciences customers is rising, though tariffs and rising costs are pressuring results.

Source Zacks Investment Research Significance moderate Impact financial impact Risk improving

Read the article →

No specific new event or data release was reported.

Source yahoo.com Significance moderate Impact financial impact Risk improving

Read the article →

STERIS (STE) is buying Xodus Medical for $2.1 billion in cash and has lined up $2 billion in short-term bridge financing to help pay for it, expanding its specialty surgical equipment business.

Source gurufocus.com Significance moderate Impact financial impact Risk improving

Read the article →

Steris PLC has agreed to buy Xodus Medical Inc. and some affiliates for $2.1 billion. Jones Day is advising Steris, and Morgan Lewis & Bockius is representing Xodus.

Source law360.com Significance moderate Impact financial impact Risk improving

Read the article →

Steris announced a $2.1bn deal to buy Xodus Medical, a maker of surgical safety devices whose flagship product is the Pink Pad patient positioning system. The acquisition is framed as a way to expand Steris's lineup of surgical safety products.

Source medicaldevice-network.com Significance minor Impact product Risk improving

Read the article →

Nearest peers by size

Health Care
TickerCompanyGradeMkt capP/EBeta
THCTenet Healthcare CorpB$21.52B9.601.22Compare
GHGuardant Health IncC+$21.28B—1.71Compare
ZBHZimmer Biomet Holdings, IncB+$18.37B22.380.49Compare
LHLabcorp Holdings IncA-$25.79B25.730.89Compare
DGXQuest Diagnostics IncA-$25.94B24.420.56Compare
ALCAlcon AGB+$27.54B40.811.07Compare
GEHCGE Healthcare Technologies IncB$31.42B15.830.83Compare
SOLVSolventum CorpB+$14.61B10.180.75Compare

You just read one holding. Clavix reads the whole portfolio.

Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.